{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:33:55Z","timestamp":1789781635801,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jinf.2024.106177","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T21:34:43Z","timestamp":1715031283000},"page":"106177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study"],"prefix":"10.1016","volume":"89","author":[{"given":"Freja C.M.","family":"Kirsebom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1301-5653","authenticated-orcid":false,"given":"Jamie","family":"Lopez Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6998-447X","authenticated-orcid":false,"given":"Alex","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"0","key":"10.1016\/j.jinf.2024.106177_bib1","article-title":"Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study","volume":"0","author":"Kirsebom","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2024.106177_bib2","article-title":"Effectiveness of the Sanofi\/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original\/Omicron BA.4-5) bivalent vaccines against hospitalisation in England","volume":"71","author":"Kirsebom FCM","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.jinf.2024.106177_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15585\/mmwr.mm7205e1","volume":"72","author":"Link-Gelles","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"10.1016\/j.jinf.2024.106177_bib4","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.15585\/mmwr.mm715152e1","article-title":"Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults\u2014VISION network, nine states, September-November 2022","volume":"71","author":"Tenforde","year":"2022","journal-title":"MMWR Morbidity Mortality Wkly Rep"},{"key":"10.1016\/j.jinf.2024.106177_bib5","unstructured":"UK Health Security Agency. National Influenza and COVID-19 surveillance report: Week 9 report (up to week 8 data) 2024 [Available from: https:\/\/assets.publishing.service.gov.uk\/media\/65e07c292f2b3b001c7cd778\/Weekly-flu-and-COVID-19-surveillance-report-week-9.pdf."},{"issue":"2","key":"10.1016\/j.jinf.2024.106177_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2024.106177_bib7","unstructured":"World Health Organisation. Initial risk evaluation of JN.1, 19 December 2023 2023 [Available from: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/18122023_jn.1_ire_clean.pdf?sfvrsn=6103754a_3."},{"key":"10.1016\/j.jinf.2024.106177_bib8","unstructured":"Department of Health & Social Care. Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020 [Available from: www.gov.uk\/government\/publications\/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020\/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020."},{"key":"10.1016\/j.jinf.2024.106177_bib9","unstructured":"Joint Committee on Vaccination and Immunisation. Joint Committee on Vaccination and Immunisation (JCVI) statement on COVID-19 vaccinations in 2022: 21 February 2022. 2022."},{"key":"10.1016\/j.jinf.2024.106177_bib10","unstructured":"Joint Committee on Vaccination and Immunisation. JCVI statement on spring 2023 COVID-19 vaccinations, 22 February 2023 2023 [Available from: https:\/\/www.gov.uk\/government\/publications\/spring-2023-covid-19-vaccination-programme-jcvi-advice-22-february-2023\/jcvi-statement-on-spring-2023-covid-19-vaccinations-22-february-2023."},{"key":"10.1016\/j.jinf.2024.106177_bib11","unstructured":"Joint Committee on Vaccination and Immunisation. JCVI updated statement on the COVID-19 vaccination programme for autumn 2022. 2022 [Available from: https:\/\/www.gov.uk\/government\/publications\/jcvi-updated-statement-on-the-covid-19-vaccination-programme-for-autumn-2022."},{"key":"10.1016\/j.jinf.2024.106177_bib12","unstructured":"Joint Committee on Vaccination and Immunisation. JCVI statement on the COVID-19 vaccination programme for autumn 2023\u2014update 7 July 2023. 2024 [Available from: https:\/\/www.gov.uk\/government\/publications\/covid-19-autumn-2023-vaccination-programme-jcvi-update-7-july-2023\/jcvi-statement-on-the-covid-19-vaccination-programme-for-autumn-2023-update-7-july-2023."},{"issue":"1","key":"10.1016\/j.jinf.2024.106177_bib13","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1038\/s41467-022-33378-7","article-title":"Effectiveness of COVID-19 vaccines against Omicron and delta hospitalisation, a test negative case-control study","volume":"13","author":"Stowe","year":"2022","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.jinf.2024.106177_bib14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529)","volume":"386","author":"Andrews","year":"2022","journal-title":"Var N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106177_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2022.104974","article-title":"Monitoring the COVID-19 immunisation programme through a national immunisation Management system\u2014England\u2019s experience","volume":"170","author":"Tessier","year":"2023","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.jinf.2024.106177_bib16","unstructured":"NHS Digital. Cohorting as a Service (CaaS) 2022 [Available from: https:\/\/digital.nhs.uk\/services\/cohorting-as-a-service-caas."},{"key":"10.1016\/j.jinf.2024.106177_bib17","unstructured":"NHS Digital. Secondary Uses Service (SUS) 2022 [Available from: https:\/\/digital.nhs.uk\/services\/secondary-uses-service-sus."},{"key":"10.1016\/j.jinf.2024.106177_bib18","series-title":"COVID-19: The Green Book, Chapter 14a. Immunisation Against Infectious Diseases","author":"UK Health Security Agency","year":"2020"},{"issue":"7","key":"10.1016\/j.jinf.2024.106177_bib19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1473-3099(22)00309-7","article-title":"COVID-19 vaccine effectiveness against the Omicron (BA.2) variant in England","volume":"22","author":"Kirsebom","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2024.106177_bib20","article-title":"Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort","volume":"36","author":"Kirwan","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jinf.2024.106177_bib21","unstructured":"UK Health Security Agency. UK Coronavirus Dashboard; Healthcare in England 2024 [Available from: https:\/\/coronavirus.data.gov.uk\/details\/healthcare?areaType=nation&areaName=England."},{"issue":"2","key":"10.1016\/j.jinf.2024.106177_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(23)00746-6","article-title":"Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study","volume":"24","author":"Hansen","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2024.106177_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm7304a2","volume":"73","author":"Link-Gelles","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.jinf.2024.106177_bib24","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.7.2400076","article-title":"2023\/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)","volume":"29","author":"Skowronski","year":"2024","journal-title":"Eur Surveill"},{"issue":"1","key":"10.1016\/j.jinf.2024.106177_bib25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cid\/ciac234","article-title":"Effects of confounding bias in coronavirus disease 2019 (COVID-19) and influenza vaccine effectiveness test-negative designs due to correlated influenza and COVID-19 vaccination behaviors","volume":"75","author":"Doll","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2024.106177_bib26","doi-asserted-by":"crossref","unstructured":"Moustsen-Helms I., Bager P., Larsen T., Trier M\u00f8ller F., Vestergaard L., Christiansen L., et al. Relative vaccine protection, disease severity and symptoms associated with infection with SARS-CoV-2 Omicron subvariant Ba.2.86 and descendent Jn.1: a Danish nationwide register-based study. Preprint with SSRN. 2024.","DOI":"10.2139\/ssrn.4716761"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T22:35:23Z","timestamp":1718404523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0163445324001117"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106177","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106177"}}